23-Apr-2024
Globe Newswire (Wed, 24-Apr 7:00 AM ET)
TipRanks (Tue, 23-Apr 6:20 AM ET)
Aslan Pharmaceuticals’ Eblasakimab Shows Promise
TipRanks (Mon, 22-Apr 9:58 AM ET)
Globe Newswire (Mon, 22-Apr 8:45 AM ET)
ASLAN Pharma Faces Nasdaq Compliance Challenge
TipRanks (Fri, 19-Apr 5:27 PM ET)
ASLAN Pharmaceuticals announces receipt of Nasdaq notice
Seeking Alpha News (Fri, 19-Apr 5:19 PM ET)
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
Globe Newswire (Fri, 19-Apr 5:10 PM ET)
Globe Newswire (Fri, 12-Apr 8:00 AM ET)
Globe Newswire (Wed, 27-Mar 8:07 AM ET)
ASLAN Pharmaceuticals Announces $5 Million Registered Direct Offering
Globe Newswire (Tue, 12-Mar 2:34 PM ET)
ASLAN Pharmaceuticals Ltd is a clinical-stage immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients. The company is evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease. The Company's major business is research and development and operates only in one single segment.
Aslan Pharmaceuticals Limited - American Depositary Shares trades on the NASDAQ stock market under the symbol ASLN.
As of April 23, 2024, ASLN stock price climbed to $0.47 with 1,350,964 million shares trading.
ASLN has a beta of 2.08, meaning it tends to be more sensitive to market movements. ASLN has a correlation of 0.03 to the broad based SPY ETF.
ASLN has a market cap of $10.61 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, ASLN stock traded as high as $96.75 and as low as $.39.
The top ETF exchange traded funds that ASLN belongs to (by Net Assets): SPEM.
ASLN has underperformed the market in the last year with a price return of -88.2% while the SPY ETF gained +24.3%. ASLN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -13.8% and -17.7%, respectively, while the SPY returned +4.6% and -2.6%, respectively.
ASLN support price is $.42 and resistance is $.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ASLN stock will trade within this expected range on the day.